Foo-Lim Yeh

Foo-Lim Yeh is currently the Allergan Aesthetics, Neuroscience, and Specialty Head in Regulatory Affairs at AbbVie, a position they have held since 2023. Prior to this, they served as a Director of Regulatory Affairs at AbbVie from 2020 to 2023 and held various roles at Allergan between 2018 and 2020. They also contributed to the regulatory field at Wyeth Pharmaceuticals as a Regulatory Affairs Project Manager, successfully overseeing the registration of Canada’s first oncology drug, TORISEL™. Foo-Lim started their career as a Compliance Associate at Wyeth Pharmaceuticals in 2002. They are currently pursuing a Master of Science in Biochemistry at the University of Guelph.